1. Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
   Mohammad Aarif Siddiqui et al, 2021, British Journal of Cancer CrossRef
2. Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation
   Dandan Xu et al, 2021, European Journal of Medicinal Chemistry CrossRef
3. Silencing AXL by covalent siRNA-gelatin-antibody nanoconjugate inactivates mTOR/EMT pathway and stimulates p53 for TKI sensitization in NSCLC
   Dhananjay Suresh et al, 2019, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
4. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy
   Jeffrey C. Thompson et al, 2020, Lung Cancer CrossRef
5. MicroRNA 34a–AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells
   Dansaem Lim et al, 2020, Genes CrossRef
6. AXL Inhibitors: Status of Clinical Development
   Sheena Bhalla et al, 2023, Current Oncology Reports CrossRef
7. Hepatocyte-targeted delivery using oleanolic acid-loaded liposomes for enhanced hepatocellular carcinoma therapy
   Xinbo Wei et al, 2023, Biomaterials Science CrossRef